Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-16-007629
Filing Date
2016-12-21
Accepted
2016-12-21 19:03:34
Documents
1
Period of Report
2016-12-19

Document Format Files

Seq Description Document Type Size
1 form4-12212016_041225.html 4  
1 form4-12212016_041225.xml 4 11677
  Complete submission text file 0001415889-16-007629.txt   13029
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3911 SORRENTO VALLEY BLVD. SAN DIEGO CA 92121
Business Address
Baity Glenn (Reporting) CIK: 0001487100 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 162064846